Full Name
Chakalaroski, Petar
Variants
Cakalaroski Petar
Chakalaroski Petar
Cakalaroski P
Chakalaroski P
Чакалароски Петар
Чакалароски П
П Чакалароски
Петар Чакалароски
P Chakalaroski
P Cakalaroski
Petar Chakalaroski
Petar Cakalaroski
 
Main Affiliation
 
Email
petar.cakalaroski@medf.ukim.edu.mk
 
 
Loading... 2 0 5 0 false
Loading... 3 0 5 0 false

Refined By:
Author:  Petar Chakalaroski
Date Issued:  2018

Results 1-5 of 5 (Search time: 0.04 seconds).

PreviewTitleAuthor(s)Issue DateType
1Adjuvant chemotherapy and radiotherapy for Stage III endometrial cancer: Impact on SurvivalPetreska, Bojana ; Veljanoska, Slavica; Stojkovski, Igor ; Chakalaroski, Petar ; Klisarovska, Violeta ; Petkovska, GordanaJun-2018Proceeding article
2Brachytherapy alone in the postoperative treatment of stage I endometrial carcinomaKlisarovska V ; Chakalaroski P ; Stojmenovska V; Stojkovski I ; Dimoski I17-Nov-2018Proceeding article
3Dose differences between two-dimensional and three-dimensional approach to high dose brachytherapy dose reporting of organs at risk in inoperable cervical cancer treatmentChakalaroski P ; Klisarovska V 22-Jun-2018Proceeding article
4The effect from Paclitaxel/Carboplatin regimen to advanced ovarian carcinomaVioleta Klisarovska ; Petar Chakalaroski ; Igor Stojkovski ; Gordana Petkovska18-Jun-2018Proceeding article
5RELATIONSHIP BETWEEN O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE (MGMT) PROMOTER METHYLATION STATUS AND TUMOR SIZE ON PREOPERATIVE CONTRAST ENHANCED MRI IN PATIENTS WITH GLIOBLASTOMA MULTIFORME – SINGLE INSTITUTION EXPERIENCEStojkovski, Igor ; Petkovska, Gordana; Petreska, Bojana ; Chakalaroski, Petar ; Bojovska, Valentina; Klisarovska, Violeta 1-Jun-2018Proceeding article